Veracyte
VCYT
53 hedge funds and large institutions have $92.7M invested in Veracyte in 2014 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 10 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 12
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
6% more funds holding
Funds holding: 50 → 53 (+3)
38% less capital invested
Capital invested by funds: $150M → $92.7M (-$57.8M)
Top Buyers
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$9.52M |
| 2 |
ECP
Elk Creek Partners
Denver,
Colorado
|
-$3.48M |
| 3 |
PC
Pier Capital
Stamford,
Connecticut
|
-$3.4M |
| 4 |
ACM
Atika Capital Management
New York
|
-$1.93M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.61M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $18 | +$23.7K | +1,808 | New |
|
|
VAM
52
Visium Asset Management
New York
| – | -$9.52M | -556,000 | Closed |
|
|
ECP
53
Elk Creek Partners
Denver,
Colorado
| – | -$3.48M | -203,359 | Closed |
|
|
PC
54
Pier Capital
Stamford,
Connecticut
| – | -$3.4M | -198,736 | Closed |
|
|
ACM
55
Atika Capital Management
New York
| – | -$1.93M | -112,500 | Closed |
|
56
Goldman Sachs
New York
| – | -$176K | -10,308 | Closed |
|
|
VFA
57
Virtus Fund Advisers
Hartford,
Connecticut
| – | -$9K | -554 | Closed |
|
|
MTIP
58
Magee Thomson Investment Partners
San Diego,
California
| – | -$6K | -344 | Closed |
|
|
U
59
UBS
Zurich,
Switzerland
| – | -$6K | -333 | Closed |
|
60
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$2K | -130 | Closed |
|
61
US Bancorp
Minneapolis,
Minnesota
| – | -$1K | -47 | Closed |
|
62
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$13 | -1 | -3% |
|
63
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$368 | +28 | +88% |
|
VCYT Hedge Fund Activity: Q3 2014 in Review
53 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2014, worth a combined $92.7M — down 38% from $150M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new VCYT positions and 10 closed out — a net gain of 3 holders — while 18 added to existing stakes and 12 trimmed.
The largest buyer was Eventide Asset Management, adding an estimated $10M. The largest seller was Visium Asset Management, exiting entirely with an estimated $9.52M sold.
- 53 institutional investors held Veracyte (VCYT) as of Q3 2014, up from 50 in Q2 2014.
- Funds reported $92.7M of Veracyte stock for Q3 2014, down 38% quarter-over-quarter.
- 13 funds opened new Veracyte positions in Q3 2014 and 10 closed out, a net change of +3 holders.
- The largest Veracyte buyer in Q3 2014 was Eventide Asset Management, an estimated $10M added.
- The largest Veracyte seller in Q3 2014 was Visium Asset Management, an estimated $9.52M sold.
Based on aggregated 13F filings for Q3 2014.